Table 2. Cox regression analysis of Rab1A expression and clinicopathologic features in cohort I and cohort II.
| Clinical parameters | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| RR | 95% CI | p value | RR | 95% CI | p value | |
| Chort I | ||||||
| Rab1A Exp (High vs Low) | 7.863 | 3.128-19.768 | <0.001 | 7.247 | 2.833-18.539 | <0.001 |
| Age (≤60 vs >60) | 0.982 | 0.961-1.004 | 0.114 | 0.999 | 0.978-1.020 | 0.911 |
| Gender (Female vs Male) | 0.810 | 0.409-1.607 | 0.547 | 1.065 | 0.490-2.312 | 0.874 |
| TNM Stage (III vs I-II) | 5.613 | 3.242-9.719 | <0.001 | 4.104 | 2.041-8.251 | <0.001 |
| Tumor Size (cm) (>5 vs ≤5) | 1.684 | 0.931-3.044 | 0.085 | 1.210 | 0.635-2.306 | 0.561 |
| Tumor Number (>1 vs 1) | 3.099 | 1.803-5.325 | <0.001 | 1.069 | 0.727-1.574 | 0.734 |
| Recurrence (Yes vs No) | 2.895 | 1.657-5.057 | <0.001 | 2.612 | 1.450-4.705 | 0.002 |
| Chort II | ||||||
| Rab1A Exp (High vs Low) | 1.726 | 1.465-2.986 | 0.009 | 2.289 | 1.224-4.281 | 0.010 |
| Age (≤60 vs >60) | 0.929 | 0.551-1.566 | 0.782 | 0.962 | 0.570-1.625 | 0.885 |
| Gender (Female vs Male) | 1.253 | 0.500-3.141 | 0.619 | 1.327 | 0.522-3.370 | 0.353 |
| TNM Stage (III vs I-II) | 2.409 | 1.410-4.116 | 0.001 | 2.342 | 1.260-4.351 | 0.007 |
| tumor Size (cm) (>5 vs ≤5) | 2.106 | 1.195-3.709 | 0.010 | 1.212 | 0.633-2.323 | 0.562 |
| Tumor Number (>1 vs 1) | 1.514 | 0.648-3.533 | 0.338 | |||